Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-drug interaction of TAS5315 with itraconazole in healthy adults
jRCT2071220117Phase 1Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of TAS5315, sponsored by Taiho Pharmaceutical Co., Ltd. Primary endpoints: Cmax of TAS5315, AUClast of TAS5315 and 1 more. Started May 2023; status: completed.
02
Drugs
TAS5315
Beyond the preview
Go deeper on jRCT2071220117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071220117.